These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12904687)

  • 41. Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore.
    Peterson BZ; Catterall WA
    Mol Pharmacol; 2006 Aug; 70(2):667-75. PubMed ID: 16675661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcicludine binding to the outer pore of L-type calcium channels is allosterically coupled to dihydropyridine binding.
    Wang X; Du L; Peterson BZ
    Biochemistry; 2007 Jun; 46(25):7590-8. PubMed ID: 17536837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
    Freeze BS; McNulty MM; Hanck DA
    Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N- and L-type calcium channels blocker cilnidipine ameliorates neuropathic pain.
    Yamamoto S; Suzuki Y; Ono H; Kume K; Ohsawa M
    Eur J Pharmacol; 2016 Dec; 793():66-75. PubMed ID: 27823932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels.
    Klint JK; Berecki G; Durek T; Mobli M; Knapp O; King GF; Adams DJ; Alewood PF; Rash LD
    Biochem Pharmacol; 2014 May; 89(2):276-86. PubMed ID: 24561180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death.
    Yagami T; Ueda K; Sakaeda T; Itoh N; Sakaguchi G; Okamura N; Hori Y; Fujimoto M
    Biochem Pharmacol; 2004 Mar; 67(6):1153-65. PubMed ID: 15006551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of manganese currents by 1, 4-dihydropyridines, isoproterenol and forskolin in rabbit ventricular cells.
    Masumiya H; Tsujikawa H; Hino N; Ochi R
    Pflugers Arch; 2003 Sep; 446(6):695-701. PubMed ID: 12827360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biophysical and pharmacological characterization of voltage-gated calcium currents in turtle auditory hair cells.
    Schnee ME; Ricci AJ
    J Physiol; 2003 Jun; 549(Pt 3):697-717. PubMed ID: 12740421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different pharmacological properties of the optical isomers of MN9202, a novel 1,4-dihydropyridine Ca+ channel modulator, in rat ventricular myocytes.
    Li XQ; Cao W; Zeng AG; Yang ZF; Xing B; Dong L; Zhang HF; Mei QB
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):817-25. PubMed ID: 20374262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
    Schuster A; Lacinová L; Klugbauer N; Ito H; Birnbaumer L; Hofmann F
    EMBO J; 1996 May; 15(10):2365-70. PubMed ID: 8665843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between calcium channels and SK channels in midbrain dopamine neurons and their impact on pacemaker regularity: Contrasting roles of N- and L-type channels.
    de Vrind V; Scuvée-Moreau J; Drion G; Hmaied C; Philippart F; Engel D; Seutin V
    Eur J Pharmacol; 2016 Oct; 788():274-279. PubMed ID: 27364758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence of human-like Ca
    Baig AM; Rana Z; Waliani N; Karim S; Rajabali M
    Chem Biol Drug Des; 2019 Mar; 93(3):351-363. PubMed ID: 30362253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unveiling (-)-Englerin A as a Modulator of L-Type Calcium Channels.
    Rodrigues T; Sieglitz F; Somovilla VJ; Cal PM; Galione A; Corzana F; Bernardes GJ
    Angew Chem Int Ed Engl; 2016 Sep; 55(37):11077-81. PubMed ID: 27391219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium involvement in the luminescence control of three ophiuroid species (Echinodermata).
    Dewael Y; Mallefet J
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Feb; 131(2):153-60. PubMed ID: 11879782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiology and Evolution of Voltage-Gated Calcium Channels in Early Diverging Animal Phyla: Cnidaria, Placozoa, Porifera and Ctenophora.
    Senatore A; Raiss H; Le P
    Front Physiol; 2016; 7():481. PubMed ID: 27867359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. C-terminal tailoring of L-type calcium channel function.
    Striessnig J
    J Physiol; 2007 Dec; 585(Pt 3):643-4. PubMed ID: 18084049
    [No Abstract]   [Full Text] [Related]  

  • 57. Ca
    Conrad R; Kortzak D; Guzman GA; Miranda-Laferte E; Hidalgo P
    Traffic; 2021 Jun; 22(6):180-193. PubMed ID: 33890356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ca
    Pinggera A; Striessnig J
    J Physiol; 2016 Oct; 594(20):5839-5849. PubMed ID: 26842699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The mammalian skeletal muscle DHPR has larger Ca
    Schrötter K; Dayal A; Grabner M
    Cell Calcium; 2017 Jan; 61():22-31. PubMed ID: 27793347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple C-terminal tail Ca(2+)/CaMs regulate Ca(V)1.2 function but do not mediate channel dimerization.
    Kim EY; Rumpf CH; Van Petegem F; Arant RJ; Findeisen F; Cooley ES; Isacoff EY; Minor DL
    EMBO J; 2010 Dec; 29(23):3924-38. PubMed ID: 20953164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.